| Quarter | Score |
|---|---|
| 2022-Q1 | 49.3 |
| 2022-Q3 | 41.2 |
| 2022-Q4 | 51.1 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 63.4 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.7 |
| 2024-Q1 | 73.2 |
| 2024-Q2 | 72.0 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.6 |
| 2025-Q2 | 75.1 |
| 2025-Q3 | 74.2 |
| 2025-Q4 | 74.5 |
| 2026-Q1 | 74.1 |
| 2026-Q2 | 74.0 |
Funds reducing exposure or consensus momentum fading
Trading +83.1% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold NUE. Avg conviction: 0.1%. Net trimming. First tracked at $139.94 (current +83.1% vs tracked).
Berkshire Hathaway has 0.1% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 0.1% | Reduce |
| Citadel Advisors | 0.0% | Reduce |